Literature DB >> 15677490

A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function.

Darcy B Carr1, Kristina M Utzschneider, Edward J Boyko, Pamela J Asberry, Rebecca L Hull, Keiichi Kodama, Holly S Callahan, Colleen C Matthys, Donna L Leonetti, Robert S Schwartz, Steven E Kahn, Wilfred Y Fujimoto.   

Abstract

Lifestyle modification reduces the risk of developing type 2 diabetes and may have its effect through improving insulin sensitivity, beta-cell function, or both. To determine whether diet and exercise improve insulin sensitivity and/or beta-cell function and to evaluate these effects over time, we quantified insulin sensitivity and the acute insulin response to glucose (AIRg) in 62 Japanese Americans (age 56.5 +/- 1.3 years; mean +/- SE) with impaired glucose tolerance (IGT) who were randomized to the American Heart Association (AHA) Step 2 diet plus endurance exercise (n = 30) versus the AHA Step 1 diet plus stretching (n = 32) for 24 months. beta-Cell function (disposition index [DI]) was calculated as S(i) x AIRg, where S(i) is the insulin sensitivity index. The incremental area under the curve for glucose (incAUCg) was calculated from a 75-g oral glucose tolerance test. Intra-abdominal fat (IAF) and subcutaneous fat (SCF) areas were measured by computed tomography. At 24 months, the Step 2/endurance group had lower weight (63.1 +/- 2.4 vs. 71.3 +/- 2.9 kg; P = 0.004) and IAF (75.0 +/- 7.9 vs. 112.7 +/- 10.4 cm(2); P = 0.03) and SCF (196.5 +/- 18.0 vs. 227.7 +/- 19.9 cm(2); P < 0.001) areas, greater S(i) (4.7 +/- 0.5 vs. 3.3 +/- 0.3 x 10(-5) min . pmol(-1) . l(-1); P = 0.01), and a trend toward lower AIRg (294.9 +/- 50.0 vs. 305.4 +/- 30.0 pmol/l; P = 0.06) and incAUCg (8,217.3 +/- 350.7 vs. 8,902.0 +/- 367.2 mg . dl(-1) . 2 h(-1); P = 0.08) compared with the Step 1/stretching group after adjusting for baseline values. There was no difference in the DI (P = 0.7) between the groups. S(i) was associated with changes in weight (r = -0.426, P = 0.001) and IAF (r = -0.395, P = 0.003) and SCF (r = -0.341, P = 0.01) areas. Thus, the lifestyle modifications decreased weight and central adiposity and improved insulin sensitivity in Japanese Americans with IGT. However, such changes did not improve beta-cell function, suggesting that this degree of lifestyle modifications may be limited in preventing type 2 diabetes over the long term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677490     DOI: 10.2337/diabetes.54.2.340

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

2.  Evaluating a Culturally Competent Health Coach Intervention for Chinese American Patients with Diabetes.

Authors:  Susan L Ivey; Winston Tseng; Elaine Kurtovich; Ben Lui; Rosy Chang Weir; Jing Liu; Hui Song; May Wang; Alan Hubbard
Journal:  Diabetes Spectr       Date:  2012-05-01

Review 3.  Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

Authors:  Ethan M Balk; Amy Earley; Gowri Raman; Esther A Avendano; Anastassios G Pittas; Patrick L Remington
Journal:  Ann Intern Med       Date:  2015-09-15       Impact factor: 25.391

4.  Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.

Authors:  Edward Lin; Zhe Liang; Jennifer Frediani; Scott S Davis; John F Sweeney; Thomas R Ziegler; Lawrence S Phillips; Nana Gletsu-Miller
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-17       Impact factor: 4.310

5.  Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

Authors:  Janet Lo; Sung Min You; Bridget Canavan; James Liebau; Greg Beltrani; Polyxeni Koutkia; Linda Hemphill; Hang Lee; Steven Grinspoon
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

Review 6.  Comparison of control fasting plasma glucose of exercise-only versus exercise-diet among a pre-diabetic population: a meta-analysis.

Authors:  L Zheng; J Wu; G Wang; G Persuitte; Y Ma; L Zou; L Zhang; M Zhao; J Wang; Qin Lan; Z Liu; H Fan; J Li
Journal:  Eur J Clin Nutr       Date:  2015-09-02       Impact factor: 4.016

7.  Body size and shape changes and the risk of diabetes in the diabetes prevention program.

Authors:  Wilfred Y Fujimoto; Kathleen A Jablonski; George A Bray; Andrea Kriska; Elizabeth Barrett-Connor; Steven Haffner; Robert Hanson; James O Hill; Van Hubbard; E Stamm; F Xavier Pi-Sunyer
Journal:  Diabetes       Date:  2007-03-15       Impact factor: 9.461

Review 8.  The role of physical activity in the management of impaired glucose tolerance: a systematic review.

Authors:  T Yates; K Khunti; F Bull; T Gorely; M J Davies
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

9.  Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity.

Authors:  Maki Goto; Akemi Morita; Atsushi Goto; Kijo Deura; Satoshi Sasaki; Naomi Aiba; Takuro Shimbo; Yasuo Terauchi; Motohiko Miyachi; Mitsuhiko Noda; Shaw Watanabe
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Self-reported physical activity is associated with β-cell function in Mexican American adults.

Authors:  Zhanghua Chen; Mary Helen Black; Richard M Watanabe; Enrique Trigo; Miwa Takayanagi; Jean M Lawrence; Thomas A Buchanan; Anny H Xiang
Journal:  Diabetes Care       Date:  2012-12-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.